Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS.

Marcus Werner KochJop MostertPavle RepovicJames D BowenEva StrijbisBernard UitdehaagGary Cutter

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)

Worsening of the EDSS and T25FW was associated with two commonly used HRQOL measures. These outcomes therefore appear to be more patient relevant than either the NHPT or SDMT in the context of a 2-year clinical trial.

Keyphrases

clinical trial
multiple sclerosis
high resolution
mass spectrometry
case report
phase ii
open label
type diabetes
adipose tissue
photodynamic therapy